291 related articles for article (PubMed ID: 27271157)
1. A Movement Monitor Based on Magneto-Inertial Sensors for Non-Ambulant Patients with Duchenne Muscular Dystrophy: A Pilot Study in Controlled Environment.
Le Moing AG; Seferian AM; Moraux A; Annoussamy M; Dorveaux E; Gasnier E; Hogrel JY; Voit T; Vissière D; Servais L
PLoS One; 2016; 11(6):e0156696. PubMed ID: 27271157
[TBL] [Abstract][Full Text] [Related]
2. Upper limb strength and function changes during a one-year follow-up in non-ambulant patients with Duchenne Muscular Dystrophy: an observational multicenter trial.
Seferian AM; Moraux A; Annoussamy M; Canal A; Decostre V; Diebate O; Le Moing AG; Gidaro T; Deconinck N; Van Parys F; Vereecke W; Wittevrongel S; Mayer M; Maincent K; Desguerre I; Thémar-Noël C; Cuisset JM; Tiffreau V; Denis S; Jousten V; Quijano-Roy S; Voit T; Hogrel JY; Servais L
PLoS One; 2015; 10(2):e0113999. PubMed ID: 25643053
[TBL] [Abstract][Full Text] [Related]
3. Innovative methods to assess upper limb strength and function in non-ambulant Duchenne patients.
Servais L; Deconinck N; Moraux A; Benali M; Canal A; Van Parys F; Vereecke W; Wittevrongel S; Mayer M; Desguerre I; Maincent K; Themar-Noel C; Quijano-Roy S; Serari N; Voit T; Hogrel JY
Neuromuscul Disord; 2013 Feb; 23(2):139-48. PubMed ID: 23219352
[TBL] [Abstract][Full Text] [Related]
4. Respiratory and upper limb function as outcome measures in ambulant and non-ambulant subjects with Duchenne muscular dystrophy: A prospective multicentre study.
Ricotti V; Selby V; Ridout D; Domingos J; Decostre V; Mayhew A; Eagle M; Butler J; Guglieri M; Van der Holst M; Jansen M; Verschuuren JJGM; de Groot IJM; Niks EH; Servais L; Straub V; Voit T; Hogrel JY; Muntoni F
Neuromuscul Disord; 2019 Apr; 29(4):261-268. PubMed ID: 30852071
[TBL] [Abstract][Full Text] [Related]
5. Monitoring daily physical activity of upper extremity in young and adolescent boys with Duchenne muscular dystrophy: A pilot study.
van der Geest A; Essers JMN; Bergsma A; Jansen M; de Groot IJM
Muscle Nerve; 2020 Mar; 61(3):293-300. PubMed ID: 31742708
[TBL] [Abstract][Full Text] [Related]
6. Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data.
Pane M; Coratti G; Brogna C; Mazzone ES; Mayhew A; Fanelli L; Messina S; D'Amico A; Catteruccia M; Scutifero M; Frosini S; Lanzillotta V; Colia G; Cavallaro F; Rolle E; De Sanctis R; Forcina N; Petillo R; Barp A; Gardani A; Pini A; Monaco G; D'Angelo MG; Zanin R; Vita GL; Bruno C; Mongini T; Ricci F; Pegoraro E; Bello L; Berardinelli A; Battini R; Sansone V; Albamonte E; Baranello G; Bertini E; Politano L; Sormani MP; Mercuri E
PLoS One; 2018; 13(6):e0199223. PubMed ID: 29924848
[TBL] [Abstract][Full Text] [Related]
7. Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophy.
Pane M; Mazzone ES; Fanelli L; De Sanctis R; Bianco F; Sivo S; D'Amico A; Messina S; Battini R; Scutifero M; Petillo R; Frosini S; Scalise R; Vita G; Bruno C; Pedemonte M; Mongini T; Pegoraro E; Brustia F; Gardani A; Berardinelli A; Lanzillotta V; Viggiano E; Cavallaro F; Sframeli M; Bello L; Barp A; Bonfiglio S; Rolle E; Colia G; Catteruccia M; Palermo C; D'Angelo G; Pini A; Iotti E; Gorni K; Baranello G; Morandi L; Bertini E; Politano L; Sormani M; Mercuri E
Neuromuscul Disord; 2014 Mar; 24(3):201-6. PubMed ID: 24440357
[TBL] [Abstract][Full Text] [Related]
8. Upper Limb Evaluation in Duchenne Muscular Dystrophy: Fat-Water Quantification by MRI, Muscle Force and Function Define Endpoints for Clinical Trials.
Ricotti V; Evans MR; Sinclair CD; Butler JW; Ridout DA; Hogrel JY; Emira A; Morrow JM; Reilly MM; Hanna MG; Janiczek RL; Matthews PM; Yousry TA; Muntoni F; Thornton JS
PLoS One; 2016; 11(9):e0162542. PubMed ID: 27649492
[TBL] [Abstract][Full Text] [Related]
9. The Performance of the Upper Limb scores correlate with pulmonary function test measures and Egen Klassifikation scores in Duchenne muscular dystrophy.
Lee HN; Sawnani H; Horn PS; Rybalsky I; Relucio L; Wong BL
Neuromuscul Disord; 2016; 26(4-5):264-71. PubMed ID: 27056113
[TBL] [Abstract][Full Text] [Related]
10. Unraveling upper extremity performance in Duchenne muscular dystrophy: A biophysical model.
Janssen MMHP; Harlaar J; Koopman B; de Groot IJM
Neuromuscul Disord; 2019 May; 29(5):368-375. PubMed ID: 31029531
[TBL] [Abstract][Full Text] [Related]
11. Manual ability and upper limb performance in nonambulatory stage of Duchenne muscular dystrophy.
Demir G; Bulut N; Yılmaz Ö; Karaduman A; Alemdaroğlu-Gürbüz İ
Arch Pediatr; 2020 Aug; 27(6):304-309. PubMed ID: 32718814
[TBL] [Abstract][Full Text] [Related]
12. Upper limb function in adults with Duchenne muscular dystrophy.
Bartels B; Pangalila RF; Bergen MP; Cobben NA; Stam HJ; Roebroeck ME
J Rehabil Med; 2011 Sep; 43(9):770-5. PubMed ID: 21826385
[TBL] [Abstract][Full Text] [Related]
13. Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test.
Pane M; Fanelli L; Mazzone ES; Olivieri G; D'Amico A; Messina S; Scutifero M; Battini R; Petillo R; Frosini S; Sivo S; Vita GL; Bruno C; Mongini T; Pegoraro E; De Sanctis R; Gardani A; Berardinelli A; Lanzillotta V; Carlesi A; Viggiano E; Cavallaro F; Sframeli M; Bello L; Barp A; Bianco F; Bonfiglio S; Rolle E; Palermo C; D'Angelo G; Pini A; Iotti E; Gorni K; Baranello G; Bertini E; Politano L; Sormani MP; Mercuri E
Neuromuscul Disord; 2015 Oct; 25(10):749-53. PubMed ID: 26248957
[TBL] [Abstract][Full Text] [Related]
14. Development of the Performance of the Upper Limb module for Duchenne muscular dystrophy.
Mayhew A; Mazzone ES; Eagle M; Duong T; Ash M; Decostre V; Vandenhauwe M; Klingels K; Florence J; Main M; Bianco F; Henrikson E; Servais L; Campion G; Vroom E; Ricotti V; Goemans N; McDonald C; Mercuri E;
Dev Med Child Neurol; 2013 Nov; 55(11):1038-45. PubMed ID: 23902233
[TBL] [Abstract][Full Text] [Related]
15. Towards a short questionnaire for stepwise assessment of upper limb function, pain and stiffness in Duchenne muscular dystrophy.
Janssen MMHP; Geurts ACH; de Groot IJM
Disabil Rehabil; 2018 Apr; 40(7):842-847. PubMed ID: 28084836
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen in Duchenne muscular dystrophy (TAMDMD): study protocol for a multicenter, randomized, placebo-controlled, double-blind phase 3 trial.
Nagy S; Hafner P; Schmidt S; Rubino-Nacht D; Schädelin S; Bieri O; Fischer D
Trials; 2019 Nov; 20(1):637. PubMed ID: 31752977
[TBL] [Abstract][Full Text] [Related]
17. Cumulative jerk as an outcome measure in nonambulatory Duchenne muscular dystrophy.
Fujii T; Takeshita E; Iwata Y; Yajima H; Nozaki F; Mori M; Kumada T
Brain Dev; 2019 Oct; 41(9):796-802. PubMed ID: 31213334
[TBL] [Abstract][Full Text] [Related]
18. The Association between the Respiratory System and Upper Limb Strength in Males with Duchenne Muscular Dystrophy: A New Field for Intervention?
Sobierajska-Rek A; Wasilewska E; Śledzińska K; Jabłońska-Brudło J; Małgorzewicz S; Wasilewski A; Szalewska D
Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36497753
[TBL] [Abstract][Full Text] [Related]
19. Functional levels and MRI patterns of muscle involvement in upper limbs in Duchenne muscular dystrophy.
Brogna C; Cristiano L; Tartaglione T; Verdolotti T; Fanelli L; Ficociello L; Tasca G; Battini R; Coratti G; Forcina N; De Santis R; Norcia G; Carnicella S; Colosimo C; Carlier P; Pane M; Mercuri E
PLoS One; 2018; 13(6):e0199222. PubMed ID: 29924868
[TBL] [Abstract][Full Text] [Related]
20. Development of a patient-reported outcome measure for upper limb function in Duchenne muscular dystrophy: DMD Upper Limb PROM.
Klingels K; Mayhew AG; Mazzone ES; Duong T; Decostre V; Werlauff U; Vroom E; Mercuri E; Goemans NM;
Dev Med Child Neurol; 2017 Feb; 59(2):224-231. PubMed ID: 27671699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
